Benchmark Holdings Plc

Report Publication Announcement • Aug 7, 2024

Benchmark Holdings plc

("Benchmark" or "the Company")

Notice of Q3 Results

Presentation for analysts and institutional investors Equity Development webcast for retail investors

Benchmark Holdings plc (AIM: BMK, Euronext Growth Oslo: BMK), the aquaculture biotechnology business, will announce its Q3 results for the three month period ended 30 June 2024, on Thursday 22nd August 2024.

Presentation for analysts and institutional investors at 08.00 UK time (09.00 CEST)

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a presentation for analysts and institutional investors on the day at 08.00 UK time (09.00 CEST).

The presentation will be held in person at Haakon Vlls Gate 2, Oslo, Norway. To register your interest, please contact benchmark@mhpgroup.com

A live webcast of the presentation will be available for analysts and investors to join remotely at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20240822\_11/

Equity Development webcast for retail investors at 12.00 UK time (13.00 CEST)

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a second webcast for retail investors and wealth managers at 12.00 UK time (13.00 CEST). The webcast is open to all existing and potential shareholders.

To register please visit: https://www.equitydevelopment.co.uk/news-andevents/benchmark-investor-presentation-22aug2024

Enquiries

For further information, please contact:

Benchmark Holdings plc Tel: 0114 240 9939 Trond Williksen, CEO Septima Maguire, CFO Ivonne Cantu, Investor Relations

Deutsche Numis (Nominated Adviser and Broker) Tel: 020 7260 1000

Freddie Barnfield, Duncan Monteith, Sher Shah

MHP Tel: 020 3128 8004

Equity Development Hannah Crowe

Katie Hunt, Reg Hoare benchmark@mhpgroup.com

Tel: 020 7065 2692

About Benchmark

Benchmark is a leading aquaculture biotechnology company. Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability. We bring together biology and technology to develop innovative products and solutions which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), specialist diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com.